Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07437911 · ClinicalTrials.gov registry record · NA
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
A NA study of GLP-1 and Gastrointestinal Microbiome, sponsored by Athletic Greens International.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07437911 is a NA study of GLP-1 and Gastrointestinal Microbiome that is actively recruiting participants, run by Athletic Greens International. The registered enrollment target is 120 participants, above the 85-participant average among 7 other GLP-1 trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07437911, a NA study of GLP-1 and Gastrointestinal Microbiome, is actively recruiting participants, sponsored by Athletic Greens International.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT AG1 - Nutritional Supplement
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-02 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07437911
The ClinicalTrials.gov registry entry for NCT07437911 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 7 other GLP-1 trials with a reported enrollment target (41% higher). The listed sponsor is Athletic Greens International, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with GLP-1 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07437911 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07437911 about?
NCT07437911 is a clinical study titled "A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs". This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
What is the current status of trial NCT07437911?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02. Estimated completion is 2026-08.
What conditions does trial NCT07437911 study?
This clinical trial studies the following conditions: GLP-1, Gastrointestinal Microbiome, Nutrition Status, Nutrition Intake.
What interventions are being tested in trial NCT07437911?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AG1 - Nutritional Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07437911?
This trial is sponsored by Athletic Greens International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07437911 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GLP-1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
RECRUITING · NA
-
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
RECRUITING
-
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
RECRUITING · Phase 2
-
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
RECRUITING
-
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
RECRUITING · Phase 4
-
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.